{"id":"NCT00333866","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.","officialTitle":"A 14 Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-06-06","resultsPosted":"2009-05-13","lastUpdate":"2021-02-11"},"enrollment":747,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"PLACEBO_COMPARATOR"}],"summary":"This study, will compare pregabalin with placebo for the duration of 14 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.","primaryOutcome":{"measure":"Change From Baseline in Mean Pain Score at Endpoint (Up to Week 14)","timeFrame":"Baseline, Week 14","effectByArm":[{"arm":"Placebo","deltaMin":-0.73,"sd":0.14},{"arm":"Pregabalin 300 mg","deltaMin":-1.06,"sd":0.14},{"arm":"Pregabalin 450 mg","deltaMin":-1.29,"sd":0.14},{"arm":"Pregabalin 600 mg","deltaMin":-0.96,"sd":0.14}],"pValues":[{"comp":"OG000 vs OG003","p":"0.2361"},{"comp":"OG000 vs OG002","p":"0.0132"},{"comp":"OG000 vs OG001","p":"0.1694"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":74,"countries":["Australia","Canada","Denmark","France","Germany","India","Italy","Mexico","Netherlands","Portugal","South Korea","Spain","Sweden","Switzerland","United Kingdom","Venezuela"]},"refs":{"pmids":["26694975","21965636","21639874","21039311","20584327"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081100&StudyName=Randomized%2C%20Double-Blind%2C%20Placebo-Controlled%20Trial%20Of%20Pregabalin%20%20In%20Patients%20With%20Fibromyalgia."]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":184},"commonTop":["Dizziness","Somnolence","Headache","Weight increased","Fatigue"]}}